Management of Children with Pericardial Effusion after COVID-19 on Outpatient Level of Service
Mikhail A. Martakov,
Dina S. Rusinova,
Alexey S. Bezymyanny,
Nadezda F. Mogutnova,
Pavel N. Marushko,
Irina A. Shevchenko https://doi.org/10.15690/pf.v19i3.2436
Abstract
The steady increase in the number of people infected with SARS-CoV-2 virus causing COVID-19 all over the world necessitates further study of fundamental features of pandemic spreading and clinical signs of disease, especially in children population. This article presents the experience of managing patients with pericardial effusion that has developed after new coronavirus infection COVID-19. The role of timely diagnosis of pericardial effusion, principles of its diagnostics, management, and follow-up observation on outpatient level within the pandemic are presented.
About the Authors
Mikhail A. Martakov
Children’s City Outpatient’s Clinic № 133 of Moscow City Health Department
Russian Federation
Disclosure of interest:
Russian Federation
MD, PhD
Moscow
eLibrary SPIN: 1773-7582
Disclosure of interest:
Not specified.
Dina S. Rusinova
Children’s City Outpatient’s Clinic № 133 of Moscow City Health Department;
Pirogov Russian National Research Medical University
Russian Federation
Disclosure of interest:
Russian Federation
MD, PhD
55а Smolnaya Str., 125445, Moscow
eLibrary SPIN: 8726-6132
Disclosure of interest:
Not specified.
Alexey S. Bezymyanny
Moscow Healthcare Department;
Directorate for Coordination of Medical Facilities of Moscow Healthcare Department
Russian Federation
Disclosure of interest:
Russian Federation
MD, PhD
Moscow
AuthorID: 125497
Disclosure of interest:
Not specified.
Nadezda F. Mogutnova
Pirogov Russian National Research Medical University
Russian Federation
Disclosure of interest:
Russian Federation
MD
Moscow
Disclosure of interest:
Not specified.
Pavel N. Marushko
Children’s City Outpatient’s Clinic № 133 of Moscow City Health Department
Russian Federation
Disclosure of interest:
Russian Federation
MD
Moscow
Disclosure of interest:
Not specified.
Irina A. Shevchenko
Children’s City Outpatient’s Clinic № 133 of Moscow City Health Department
Russian Federation
Disclosure of interest:
Russian Federation
MD
Moscow
Disclosure of interest:
Not specified
References
1. Namazova-Baranova LS. Coronaviral Infection (COVID-19) in Children (Situation on April 2020). Pediatricheskaya farmakologiya — Pediatric pharmacology. 2020;17(2):85–94. (In Russ). doi: https://doi.org/10.15690/pf.v17i2.2094
2. Namazova-Baranova LS, Baranov AA. Coronaviral Infection (COVID-19) in Children (Situation on June 2020). Pediatricheskaya farmakologiya — Pediatric pharmacology. 2020;17(3):162–178. (In Russ). doi: https://doi.org/10.15690/pf.v17i3.2121
3. Rusinova DS, Nikonov EL, Namazova-Baranova LS, et al. Primary Observational Results on Children Who Have Been Exposed to COVID-19 in Moscow. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2020;17(2):95–102. (In Russ). doi: https://doi.org/10.15690/pf.v17i2.2095
4. Alexandrovich YuS, Baybarina EN, Baranov AA, et al. Management of Children with Disease Caused by New Coronaviral Infection (SARS-CoV-2). Pediatricheskaya farmakologiya — Pediatric pharmacology. 2020;17(2):103–118. (In Russ). doi: https://doi.org/10.15690/pf.v17i2.2096
5. Rusinova DS, Martakov MA, Medoev SB, et al. Right Internal Carotid Artery and Basilar Artery Aneurysms After New Coronavirus Infection COVID-19 in Adolescent: Clinical Case. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2021;18(5):385–391. (In Russ). doi: https://doi.org/10.15690/pf.v18i5.2329
6. Inciardi RM, Adamo M, Lupi L, et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J. 2020;41(19):1821–1829. doi: https://doi.org/10.1093/eurheartj/ehaa388
7. Kogan EA, Berezovskiy YuS, Blagova OV, et al. Miocarditis in Patients with COVID-19 Confirmed by Immunohistochemical. Kardiologiia. 2020;60(7):4–10. (In Russ). doi: https://doi.org/10.18087/cardio.2020.7.n1209
8. Hendren NS, Drazner MH, Bozkurt B, Cooper LT. Description and proposed management of the acute COVID-19 cardiovascular syndrome. Circulation. 2020;141(23):1903–1914. doi: https://doi.org/10.1161/CIRCULATIONAHA.120.047349
9. Kaleda MI, Nikishina IP, Fedorov ES, Nasonov EL. Coronavirus Disease 2019 (COVID-19) in Children: Lessons from Pediatric Rheumatology. Nauchcno-Practicheskaya Revmatologia = Rheumatology Science and Practice. 2020;58(5):469–479. (In Russ). doi: https://doi.org/10.47360/1995-4484-2020-469-479
10. Kubanov AA, Deryabin DG. A New Look at the COVID-19 Pathogenesis: the Disease is a Generalized Viral Vasculitis, and the Lung Tissue Damage is a Variant of Angiogenic Pulmonary Edema. Annals of the Russian Academy of Medical Sciences. 2020;75(2):115–117. (In Russ). doi: https://doi.org/10.15690/vramn1347
11. Cascella M, Rajnik M, Cuomo A, et al. Features, evaluation and treatment coronavirus (COVID-19). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. Avalable online: https://www.ncbi.nlm.nih.gov/books/NBK554776/. Accessed on July 07, 2022.
12. Yi Y, Lagniton PN, Ye S, et al. COVID-19: what has been learned and to be learned about the novel coronavirus disease. Int J Biol Sci. 2020;16(10):1753–1766. doi: https://doi.org/10.7150/ijbs.45134
13. Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417– 1418.. doi: https:doi.org/10.1016/S0140-6736(20)30937-5
14. Han H, Yang L, Liu R, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020;58(7):1116–1120. doi: https://doi.org/10.1515/cclm2020-0188
15. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–847. doi: https://doi.org/10.1111/jth.14768
16. Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta. 2020;506:145–148. doi: https://doi.org/10.1016/j.cca.2020.03.022
17. Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601–615. doi: https://doi.org/10.1038/s41591-021-01283-z
18. Murkamilov IT, Aitbaev KA, Murkamilova ZhA, et al. Coronavirus Disease-2019 (COVID-19): Course and Long-term Consequences. Bulletin of Scince and Practice. 2021;7(9):271–291. (In Russ). doi: https://doi.org/10.33619/2414-2948/70/24
19. Ivannikov AA, Esaulenko AN, Vasilchenko MK, et al. COVID-19 and Cardiovascular system. Part II. Post-COVID Syndrome. Russian Sklifosovsky Journal of Emergency Medical Care. 2021;10(2):248– 258. (In Russ). doi: https://doi.org/10.23934/2223-9022202110-2-248-258
20. Kantemirova MG, Korovina OA, Novikova YY, et al. Infectious and noninfectious pericarditis in children. Pediatria. Journal n.a. G.N. Speransky. 2017;96(4):77–90. (In Russ). dоi: https://doi.org/10.24110/0031-403x-2017-96-4-77-90
21. Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36(42):2921–2964. doi: https://doi.org/10.1093/eurheartj/ehv319
22. Federal clinical guidelines for the provision of medical care to children with pericarditis. 2014. 26 p. (In Russ).
23. Imazio M, Brucato A, Pluymaekers N, et. al. Recurrent pericarditis in children and adolescents: a multicentre cohort study J Cardiovasc Med (Hagerstown). 2016;17(9):707–712. doi: https://doi.org/10.2459/JCM0000000000000300
Review
For citations:
Martakov M.A., Rusinova D.S., Bezymyanny A.S., Mogutnova N.F., Marushko P.N., Shevchenko I.A. Management of Children with Pericardial Effusion after COVID-19 on Outpatient Level of Service. Pediatric pharmacology. 2022;19(3):263-268. (In Russ.) https://doi.org/10.15690/pf.v19i3.2436
Views:
587
Email this article 